Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells

This publication has 32 references indexed in Scilit:

• Oxidized LDL Binds to CD36 on Human Monocyte-Derived Macrophages and Transfected Cell Lines
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Receptor-Specific Uptake and Degradation of Acetylated, Oxidized and Native LDL in the Human Monocytic Mono Mac 6Sr Cell Line
  Biochemical and Biophysical Research Communications, 1994
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
• Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin
  The Journal of Clinical Pharmacology, 1990
• Regulation of the mevalonate pathway
  Nature, 1990
• Preclinical evaluation of lovastatin
  The American Journal of Cardiology, 1988
• Discovery, biochemistry and biology of lovastatin
  The American Journal of Cardiology, 1988
• Isolation of the thrombospondin membrane receptor.
  Journal of Clinical Investigation, 1987
• The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
  Cell, 1984